中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
27期
93-94
,共2页
晚期癌症%芬太尼透皮贴剂%痛觉%生活质量
晚期癌癥%芬太尼透皮貼劑%痛覺%生活質量
만기암증%분태니투피첩제%통각%생활질량
Terminal cancer%Fentanyl transdermal patch%Pain%Quality of life
目的 分析芬太尼透皮贴剂对晚期癌症患者痛觉及生活质量的改善作用. 方法 随机选取该院2013年5月-2015年5月收治的50例晚期癌症患者作为研究对象, 所有患者均因口服止痛药无效或无法耐受转为应用芬太尼透皮贴剂方案,采用强度分级法比较治疗前后患者疼痛分级的改善情况,同时采取生活质量评价量表,评估治疗前后患者生活质量的改善情况. 结果 治疗前,患者疼痛分级多为5~10级,且以7~10级居多,占86.0%;治疗后,0级28例,占56.0%,1~4级17例,占34.0%,5~6级5例,占10.0%;治疗后患者无疼痛及轻度疼痛例数与治疗前对比差异有统计学意义(P<0.05);治疗后,患者疼痛状况评分上升至(74.6±6.7)分,高于治疗前(P<0.05).结论 在晚期癌症患者的疼痛干预中,采用芬太尼透皮贴剂方案,可减轻患者的疼痛感,改善其痛觉反应,促进其生活质量的恢复,值得推广.
目的 分析芬太尼透皮貼劑對晚期癌癥患者痛覺及生活質量的改善作用. 方法 隨機選取該院2013年5月-2015年5月收治的50例晚期癌癥患者作為研究對象, 所有患者均因口服止痛藥無效或無法耐受轉為應用芬太尼透皮貼劑方案,採用彊度分級法比較治療前後患者疼痛分級的改善情況,同時採取生活質量評價量錶,評估治療前後患者生活質量的改善情況. 結果 治療前,患者疼痛分級多為5~10級,且以7~10級居多,佔86.0%;治療後,0級28例,佔56.0%,1~4級17例,佔34.0%,5~6級5例,佔10.0%;治療後患者無疼痛及輕度疼痛例數與治療前對比差異有統計學意義(P<0.05);治療後,患者疼痛狀況評分上升至(74.6±6.7)分,高于治療前(P<0.05).結論 在晚期癌癥患者的疼痛榦預中,採用芬太尼透皮貼劑方案,可減輕患者的疼痛感,改善其痛覺反應,促進其生活質量的恢複,值得推廣.
목적 분석분태니투피첩제대만기암증환자통각급생활질량적개선작용. 방법 수궤선취해원2013년5월-2015년5월수치적50례만기암증환자작위연구대상, 소유환자균인구복지통약무효혹무법내수전위응용분태니투피첩제방안,채용강도분급법비교치료전후환자동통분급적개선정황,동시채취생활질량평개량표,평고치료전후환자생활질량적개선정황. 결과 치료전,환자동통분급다위5~10급,차이7~10급거다,점86.0%;치료후,0급28례,점56.0%,1~4급17례,점34.0%,5~6급5례,점10.0%;치료후환자무동통급경도동통례수여치료전대비차이유통계학의의(P<0.05);치료후,환자동통상황평분상승지(74.6±6.7)분,고우치료전(P<0.05).결론 재만기암증환자적동통간예중,채용분태니투피첩제방안,가감경환자적동통감,개선기통각반응,촉진기생활질량적회복,치득추엄.
Objective To analyze the improving effect of fentanyl transdermal patch on the pain and quality of life of terminal-cancer patients. Methods 50 cases of terminal-cancer patients admitted into the hospital from May 2013 to May 2015 were select-ed as the research object. All patients received fentanyl transdermal patch due to invalid orally taken analgesics or untolerance. The improvement of pain rating before and after the treatment was compared by strength grading method and the quality of life scale was adopted to evaluate the improvement of patients ' quality of life before and after the treatment. Results Before the treat-ment, pain grading of patients mainly was grade 5-10 and the majority was grade 7-10, accounting for 86.0%;after the treatment, there were 28 cases of grade 0, accounting for 56.0%, 17 cases of grade 1-4, accounting for 34.0% and 5 cases of grade 5-6, ac-counting for 10.0%;the contrast differences in the number of cases without pain or with mild pain after the treatment were statisti-cally significant (P < 0.05); after the treatment, the pain score of patients rose to (74.6±6.7) which was higher than that before the treatment (P<0.05). Conclusion In pain intervention of terminal-cancer patients, the use of fentanyl transdermal patch can reduce pain of patients, improve the pain response and promote the recovery of the quality of life, which is worthy of promotion.
